Administration of sodium-glucose cotransporter-2 inhibitors in kidney transplant patients with diabetes: a systematic review and meta-analysis

Administration of sodium-glucose cotransporter-2 inhibitors in kidney transplant patients with diabetes: a systematic review and meta-analysis

Introduction: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a new diabetes treatment. Considering the prescription of these medicines for kidney transplant patients, this systematic review and meta-analysis aimed to investigate the impact of SGLT2 inhibitors on kidney transplant patients. Ma...

Full description

Bibliographic Details
Main Authors: Hamidreza Khodabandeh, Zahra Bakhshizade, Mohammad Hossein Taklif, Halime Zaeri Fakhrabadi, Soleyman Alivand, Noorbakhsh Alivand, Ghazaleh Rashidizadeh, Leila Jampour, Mahsa Shirani
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2023-09-01
Series:Journal of Nephropathology
Subjects:
diabetes mellitus
sodium-glucose cotransporter two protein
human
sglt2 protein
dapagliflozin
canagliflozin
empagliflozin
kidney transplantation
renal transplantation
Online Access:https://nephropathol.com/PDF/jnp-12-e21477.pdf

Internet

https://nephropathol.com/PDF/jnp-12-e21477.pdf

Similar Items